---
figid: PMC10300409__gr1
pmcid: PMC10300409
image_filename: gr1.jpg
figure_link: /pmc/articles/PMC10300409/figure/fig1/
number: Figure 1
figure_title: ''
caption: 'Construction of recombinant LIVP strains expressing IL-15 and IL-15Rα by
  homologous recombination(A) Scheme of genetic modification of TK gene. Microphotographs
  of BHK21 cells (B) and 4T1 cells (C) infected with LIVP-RFP recombinant strain (the
  same picture was obtained for LIVP-IL15-RFP and LIVP-IL15Ra-RFP; data are not shown).
  Red immunofluorescence merged with bright field microscopy. (D) Western blotting
  analysis in cell lysate/supernatant of infected cells by LIVP-IL15-RFP (left panel)
  normalized the protein concentration to β-actin (right panel). Description: Sprntnt
  Ctrl, Lysate Ctrl, a supernatant and a lysate of the control (non-infected) cells;
  IL-15 VV Inf. Suprntnt, IL-15 VV Inf. Lysate, a supernatant and a lysate of IL-15
  VV or IL-15Ra infected cells, respectively.'
article_title: Oncolytic therapy with recombinant vaccinia viruses targeting the interleukin-15
  pathway elicits a synergistic response.
citation: Yasmin Shakiba, et al. Mol Ther Oncolytics. 2023 Jun 15;29:158-168.
year: '2023'

doi: 10.1016/j.omto.2023.05.002
journal_title: Molecular Therapy Oncolytics
journal_nlm_ta: Mol Ther Oncolytics
publisher_name: American Society of Gene & Cell Therapy

keywords:
- oncolytic virus
- vaccinia virus
- LIVP
- interleukin-15
- interleukin-15 receptor alpha
- IL-15/IL-15Rα complex
- breast adenocarcinoma
- colon carcinoma

---
